| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6cfd12fd0934c65c55334f61223231fb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-621
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-60 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60 |
| filingDate |
1983-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1985-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b36162d19a08a367809e9c69dad500e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fce6f4b58fb3ac55c2dfe7b950221350 |
| publicationDate |
1985-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4539315-A |
| titleOfInvention |
Sublingually absorbable nontoxic aspirin composition |
| abstract |
An analgesic aspirin composition in dosage form having acetylsalicylic acid and unreacted glycine in an amount equal to at least approximately 33.3% of the weight of the acetylsalicylic acid for rendering the aspirin nontoxic upon swallowing the aspirin composition, as well as rendering the aspirin sublingually absorbable. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4927816-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003104017-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7163705-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6264974-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0575613-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0575613-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0243710-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004029966-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8128961-B2 |
| priorityDate |
1982-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |